Repro Net Interest Income from 2010 to 2026
| KRMD Stock | USD 4.67 0.30 6.86% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 79 K | Current Value 74.6 K | Quarterly Volatility 59.9 K |
Check Repro Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repro Med's main balance sheet or income statement drivers, such as Depreciation And Amortization of 933.3 K, Interest Expense of 159.1 K or Total Revenue of 40.6 M, as well as many indicators such as Price To Sales Ratio of 4.95, Dividend Yield of 0.0031 or PTB Ratio of 9.91. Repro financial statements analysis is a perfect complement when working with Repro Med Valuation or Volatility modules.
Repro | Net Interest Income | Build AI portfolio with Repro Stock |
Analyzing Repro Med's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Repro Med's current valuation and future prospects.
Latest Repro Med's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Repro Med Systems over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Repro Med's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Repro Med's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Repro Net Interest Income Regression Statistics
| Arithmetic Mean | 139,714 | |
| Geometric Mean | 14,657 | |
| Coefficient Of Variation | 156.11 | |
| Mean Deviation | 176,615 | |
| Median | 13,083 | |
| Standard Deviation | 218,113 | |
| Sample Variance | 47.6B | |
| Range | 560.3K | |
| R-Value | 0.80 | |
| Mean Square Error | 18.3B | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 34,548 | |
| Total Sum of Squares | 761.2B |
Repro Net Interest Income History
About Repro Med Financial Statements
Repro Med stakeholders use historical fundamental indicators, such as Repro Med's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Repro Med investors may analyze each financial statement separately, they are all interrelated. For example, changes in Repro Med's assets and liabilities are reflected in the revenues and expenses on Repro Med's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Repro Med Systems. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 511.3 K | 536.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:Check out the analysis of Repro Med Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Health Care Equipment & Supplies sector continue expanding? Could Repro diversify its offerings? Factors like these will boost the valuation of Repro Med. Expected growth trajectory for Repro significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repro Med data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.66) | Earnings Share (0.08) | Revenue Per Share | Quarterly Revenue Growth 0.272 | Return On Assets |
Repro Med Systems's market price often diverges from its book value, the accounting figure shown on Repro's balance sheet. Smart investors calculate Repro Med's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Repro Med's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Repro Med's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Repro Med represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.